Market Overview:
The global gynecomastia treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of gynecomastia, rising awareness about available treatments, and technological advancements in the field of gynecomastia treatment. The global gynecomastia treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into drugs and surgical treatments. The drugs segment is further sub-segmented into estrogens blockers, aromatase inhibitors, progestins therapy, testosterone replacement therapy (TRT), and others. The surgical treatments segment is further sub-segmented into liposuction surgery (suction assisted lipectomy), glandular excision surgery (mastectomy), laser lipolysis surgery (laser assisted liposuction), ultrasonic assisted lipectomy surgery (UAL), and others. On the basis of application, the market is divided into hospital pharmacies; retail pharmacies; online pharmacies; and others segments which include clinics/hospitals/specialty centers that offer services for treating obesity or related problems such as diabetes mellitus or hypertension etc., research institutes & contract research organizations engaged in R&D activities for new products related to obesity management etc.).
Product Definition:
Gynecomastia is a medical condition which results in the development of abnormally large breasts in males. Treatment for gynecomastia may involve surgery to remove excess breast tissue, medication to reduce breast size, or a combination of both. Treatment for gynecomastia is important because it can improve the appearance and quality of life for men who suffer from this condition.
Drugs:
Drugs, it's usage and growth factor in Gynecomastia Treatment market is expected to witness significant growth over the forecast period. The factors that propel the growth of this sector include increasing prevalence of diseases such as breast cancer, rising awareness among people regarding early diagnosis and treatment methods along with government initiatives to provide subsidies for various drugs prescribed for gynecological disorders. Moreover, high demand for technologically advanced diagnostic procedures further propels the market during the forecast period.
Surgical Treatment:
Surgical treatment and it's usage in Gynecomastia Treatment market is a technique or a procedure where the excess breast tissue is removed by surgery. Surgical removal of gynecomastia causes an underlying health condition that may or may not get better on its own. In most cases, surgical removal of gynecomastia improves the patient’s quality of life and reduces severe discomfort caused due to gynecomastia.
Application Insights:
Based on application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. The hospital pharmacy held the largest share in 2017 due to increasing prevalence of gynecomastia and growing awareness about treatment options. According to a study published in NCBI in 2018, around 1 out of every 4 babies have some degree of breast tissue formation by the age of 2 years. Moreover, another study states that approximately 1 out of every 8 infants has some degree or other form of hyperplasia (enlargement)of glandular tissue formation from birth till 6 months old. These factors are anticipated to increase demand for drugs during this period which will subsequently fuel growth over the forecast period for this segment as well as others segments where applicable such as plastic surgery procedures and medical devices & equipment manufacturers¢â‚¬â„¢ product launches etcetera.
Regional Analysis:
North America dominated the global market in 2017. The gynecomastia treatment market is growing rapidly in this region due to rising cases of obesity and increasing awareness about available treatments. In addition, quick adoption of technologically advanced products for breast reduction is also driving the growth. For instance, physicians at Cleveland Clinic have developed a new technique using ultrasound technology that helps reduce swelling and inflammation associated with gynecomastia without surgery or medication side effects. This has led to an increase in demand for this procedure among patients from U.S.
Asia Pacific region is expected to witness lucrative growth during the forecast period owing to rise in disposable income coupled with high prevalence of obesity & related health issues such as diabetes which increases risk of developing Gynecomastia).
Growth Factors:
- Increasing awareness about gynecomastia and its treatment options among people, especially men.
- Growing number of men who are open to seeking medical help for their gynecomastia condition.
- Increasing availability and affordability of gynecomastia treatments across the world.
- Rising number of surgical procedures performed for the treatment of gynecomastia each year.
Scope Of The Report
Report Attributes
Report Details
Report Title
Gynecomastia Treatment Market Research Report
By Type
Drugs, Surgical Treatment
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Cadila Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Zydus Cadila Healthcare Ltd, Biochem Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Gynecomastia Treatment Market Report Segments:
The global Gynecomastia Treatment market is segmented on the basis of:
Types
Drugs, Surgical Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cadila Pharmaceuticals Ltd
- Sun Pharmaceuticals Industries Ltd
- Zydus Cadila Healthcare Ltd
- Biochem Pharmaceutical Industries Ltd
- Dr. Reddy's Laboratories Ltd
- Micro Nova Pharmaceuticals Ltd
- Kee Pharma Ltd
Highlights of The Gynecomastia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drugs
- Surgical Treatment
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gynecomastia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gynecomastia is a condition in which there are too many male breasts. Treatment for gynecomastia may include surgery, medication, or a combination of both.
Some of the major players in the gynecomastia treatment market are Cadila Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Zydus Cadila Healthcare Ltd, Biochem Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd.
The gynecomastia treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gynecomastia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gynecomastia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gynecomastia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gynecomastia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gynecomastia Treatment Market Size & Forecast, 2018-2028
4.5.1 Gynecomastia Treatment Market Size and Y-o-Y Growth
4.5.2 Gynecomastia Treatment Market Absolute $ Opportunity
Chapter 5 Global Gynecomastia Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gynecomastia Treatment Market Size Forecast by Type
5.2.1 Drugs
5.2.2 Surgical Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gynecomastia Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gynecomastia Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gynecomastia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gynecomastia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gynecomastia Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Gynecomastia Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gynecomastia Treatment Market Size Forecast by Type
9.6.1 Drugs
9.6.2 Surgical Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gynecomastia Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gynecomastia Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Gynecomastia Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gynecomastia Treatment Market Size Forecast by Type
10.6.1 Drugs
10.6.2 Surgical Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gynecomastia Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gynecomastia Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gynecomastia Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gynecomastia Treatment Market Size Forecast by Type
11.6.1 Drugs
11.6.2 Surgical Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gynecomastia Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gynecomastia Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Gynecomastia Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gynecomastia Treatment Market Size Forecast by Type
12.6.1 Drugs
12.6.2 Surgical Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gynecomastia Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gynecomastia Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gynecomastia Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gynecomastia Treatment Market Size Forecast by Type
13.6.1 Drugs
13.6.2 Surgical Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gynecomastia Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gynecomastia Treatment Market: Competitive Dashboard
14.2 Global Gynecomastia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cadila Pharmaceuticals Ltd
14.3.2 Sun Pharmaceuticals Industries Ltd
14.3.3 Zydus Cadila Healthcare Ltd
14.3.4 Biochem Pharmaceutical Industries Ltd
14.3.5 Dr. Reddy's Laboratories Ltd
14.3.6 Micro Nova Pharmaceuticals Ltd
14.3.7 Kee Pharma Ltd
